Healthcare Industry News: Systagenix
News Release - December 4, 2009
UK Wound Management Company Systagenix Establishes its Americas Headquarters in Quincy, MassachusettsQUINCY, Massachusetts, December 4 -- (Healthcare Sales & Marketing Network) -- Systagenix Wound Management, a leading medical device company that specializes in cutting-edge chronic wound care solutions, is expanding its operations by opening North, Central, and South American Headquarters in Quincy, Massachusetts.
The company officially opened its Quincy, Massachusetts headquarters today. Speaking at the ribbon-cutting were Massachusetts Life Sciences Center (http://www.masslifesciences.com/) President and CEO Dr. Susan Windham-Bannister, Massachusetts Office of International Trade & Investment (http://www.moiti.state.ma.us/) Executive Director Ted Carr, British Consul General to New England Dr. Phil Budden, Systagenix Wound Management CEO Steve Atkinson, Systagenix President of the Americas Scott Schorer, and South Shore Chamber of Commerce President & CEO Peter Forman.
"I initially moved to the Boston area due to its outstanding local life sciences resources," said Schorer. "That same reason was critical in our decision-making criteria as we chose to locate the Americas Office for Systagenix in Quincy. We have been very successful in retaining world-class local talent in all key medical job specialties, and look forward to partnering with local hospitals and researchers as we continue to reinforce our technology leadership in the chronic wound market."
"Our vision is to create the strongest and most admired wound care company in the world," said Atkinson. "We are well on our way towards achieving that goal with the legacy of cutting edge products and heritage of quality we inherited from Johnson & Johnson. The move to Massachusetts has helped to further our drive to achieve our vision, as we have found the environment very supportive of our efforts. We work very closely with the clinical community to develop new products, and to study the efficacy of our current products, and hope that we can leverage the strong clinical and life sciences community in the local Boston area to further those goals."
Systagenix, formerly the professional wound care division of Ethicon, a Johnson & Johnson company, continues to develop a wide array of innovative products to treat acute and chronic wounds. Their ongoing commitment and dedication is to provide the clinical community with the breakthrough solutions they need to treat and heal complex wounds. For more information about Systagenix and their products, visit http://www.Systagenix.com.
"The Life Sciences Initiative was designed to bring jobs to the Commonwealth and support vital research, and this is further proof that it is working," said Massachusetts Governor Deval Patrick. "We warmly welcome Systagenix to the Commonwealth, to Quincy and to the diverse group of pioneering companies that are making Massachusetts a global leader in medical device technology."
"We are very excited to see this innovative company come to our state, bringing new jobs and promising medical technologies" said Dr. Susan Windham-Bannister, President & CEO of the Massachusetts Life Sciences Center, the quasi-public agency charged with implementing the state's ten-year, $1 billion Life Sciences Initiative. "Massachusetts is a great place to do business for life sciences companies, both international and domestic, and we welcome Systagenix to the world's leading life sciences SuperCluster."
"We are proud to welcome Systagenix to the Commonwealth. Massachusetts is the global location for innovation and a company like Systagenix, which has been on the cutting edge of medical products since its inception, is a perfect fit," said Ted Carr, Executive Director of the Massachusetts Office of International Trade & Investment. "We look forward to working with them and watching them grow in the years to come."
"Systagenix Wound Management's new Americas headquarters in Quincy affirms why Massachusetts and its 'hub of innovation' is such an attractive destination for UK life sciences firms," said British Consul General Phil Budden. "This state is home to cutting-edge academic institutions, dynamic opportunities for collaboration and healthy competition, and the world's pre-eminent hospitals and research laboratories. As the British Government's representative in New England, I commend Systagenix for choosing Massachusetts for their first office in the United States."
"The South Shore is thrilled to welcome Systagenix as an industry leader to our region," said Peter Forman, President & CEO of the South Shore Chamber of Commerce. "A growing number of international and life science companies are discovering the South Shore and Systagenix will feel right at home here. We look forward to a bright future and long, steady growth from Systagenix."
Systagenix' decision to locate in Quincy is part of a growing trend of foreign life sciences companies locating their regional headquarters in Massachusetts. Biocell Center, an Italian company, recently opened their US headquarters in Medford, Massachusetts. Biocell Center cited the state's Life Sciences Initiative as a key factor in their decision to locate here.
In addition to clinical and new product development, Systagenix' Massachusetts-based operations will focus on expanding its support for clinicians treating chronic wounds across the entire Western Hemisphere.
"For the South Shore this is one more company within the 128 belt area that we can add to the list of life sciences companies that are booming here" said State Senator Michael Morrissey (D-Quincy). "To be chosen for the Americas headquarters indicates that we have a lot to offer in workforce access and skilled talent."
"The decision to locate the North, Central and South American headquarters of Systagenix in Quincy is a clear indicator that our state's investment in life sciences is burgeoning on the South Shore," said Assistant Majority Leader Ronald Mariano (D-Quincy). "I welcome Systagenix to the region, knowing they will reap the benefits from the Commonwealth's top talent and proven infrastructure in the life sciences industry. I am confident that Massachusetts will maintain its place at the forefront of healthcare innovation well into the future."
"Quincy is a great place to do business and I am so pleased that Systagenix chose our city as the location for its Americas headquarters," said State Representative A. Stephen Tobin (D-Quincy). "This move is an opportunity to bring jobs to our state and more specifically the South Shore."
Source: Systagenix Wound Management
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.